145 related articles for article (PubMed ID: 8775803)
1. Clinical experience with saquinavir.
Vella S
AIDS; 1995 Dec; 9 Suppl 2():S21-S25. PubMed ID: 8775803
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.
Collier AC; Coombs RW; Schoenfeld DA; Bassett RL; Timpone J; Baruch A; Jones M; Facey K; Whitacre C; McAuliffe VJ; Friedman HM; Merigan TC; Reichman RC; Hooper C; Corey L
N Engl J Med; 1996 Apr; 334(16):1011-7. PubMed ID: 8598838
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with zidovudine, didanosine and saquinavir.
Collier AC; Coombs RW; Schoenfeld DA; Bassett R; Baruch A; Corey L
Antiviral Res; 1996 Jan; 29(1):99. PubMed ID: 8721557
[TBL] [Abstract][Full Text] [Related]
4. HIV therapy advances. Update on a proteinase inhibitor.
Vella S
AIDS; 1994 Sep; 8 Suppl 3():S25-9. PubMed ID: 7840913
[TBL] [Abstract][Full Text] [Related]
5. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
6. Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.
Vella S; Galluzzo C; Giannini G; Pirillo MF; Duncan I; Jacobsen H; Andreoni M; Sarmati L; Ercoli L
Antiviral Res; 1996 Jan; 29(1):91-3. PubMed ID: 8721555
[No Abstract] [Full Text] [Related]
7. No tease this time--pros and cons of a long-awaited anti-HIV drug.
Chang HE
Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
[TBL] [Abstract][Full Text] [Related]
8. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group.
Revicki DA; Moyle G; Stellbrink HJ; Barker C
AIDS; 1999 May; 13(7):851-8. PubMed ID: 10357386
[TBL] [Abstract][Full Text] [Related]
9. 3TC and saquinavir: we need them now.
Baker R
BETA; 1995 Sep; ():3. PubMed ID: 11362889
[TBL] [Abstract][Full Text] [Related]
10. Update on HIV protease inhibitors.
Vella S
AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
[TBL] [Abstract][Full Text] [Related]
11. Roche submits NDA for Invirase.
J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
Antivir Ther; 1996 Aug; 1(3):129-40. PubMed ID: 11322246
[TBL] [Abstract][Full Text] [Related]
13. Saquinavir: combination shows survival benefit; new formulation trial recruiting.
AIDS Treat News; 1996 May; (no 246):1-2. PubMed ID: 11363484
[TBL] [Abstract][Full Text] [Related]
14. Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection.
Noble S; Faulds D
Drugs; 1996 Jul; 52(1):93-112. PubMed ID: 8799687
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibitor trials moving to next phase.
AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675
[TBL] [Abstract][Full Text] [Related]
16. Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.
Vella S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S58-61. PubMed ID: 8595511
[TBL] [Abstract][Full Text] [Related]
17. Drug-resistance patterns of saquinavir and other HIV proteinase inhibitors.
Roberts NA
AIDS; 1995 Dec; 9 Suppl 2():27-S32. PubMed ID: 8775804
[TBL] [Abstract][Full Text] [Related]
18. Ritonavir: first to prolong survival.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
Michelet C; Bellissant E; Ruffault A; Arvieux C; Delfraissy JF; Raffi F; Bazin C; Renard I; Sébille V; Chauvin JP; Dohin E; Cartier F
Clin Pharmacol Ther; 1999 Jun; 65(6):661-71. PubMed ID: 10391672
[TBL] [Abstract][Full Text] [Related]
20. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]